Professional Summary
Experienced molecular biologist with a robust academic background and significant industry experience. Skilled in teaching and mentoring, with a proven track record of leading research projects in molecular diagnostics. Committed to educating the next generation of scientists and advancing the field through innovative research and collaboration.
Education/Certification
Certified Clinical Professional- Association of Clinical Research Professionals - Aug 2024-current Certified Molecular Biologist-American Society of Clinical Pathology - March 2025-current Ph.D., Biochemistry, 2009 - Mumbai University, India MS, Biotechnology, 2003 - Guru Ghasidas University, India BS, Biology, 2001 – Rani Durgawati University, India Professional Experience
Cajal Academy Norwalk, CT 10/2024 – Current
Science Educator and Clinical Project Manager
• Mentor and educate a diverse group of neurodiverse, twice-exceptional students, facilitating their mastery of the Next Generation Science Standards curriculum for middle and high school levels.
• Employ project-based learning techniques, develop and adapt educational materials and assessment tools to accommodate diverse learning preferences, thereby establishing a nurturing and inclusive educational setting that promotes both academic progress and personal growth.
• Spearhead the creation of an organized system to track clinical data across psychology, occupational therapy, physical therapy, and speech therapy, enabling efficient data capture, database construction, and comprehensive analysis. Pfizer Vaccine R&D, Pearl River, NY 01/2022 – 02/2024 Senior Scientist, Project team lead
• Supervised a team of 7 scientists in developing & clinically validating molecular assays for phase III vaccine trials, providing training, task delegation, & mentorship to ensure high-quality results.
• Developed and optimized automated workflows for qPCR and NGS assays.
• Improved qPCR sensitivity and NGS detection accuracy, enhancing clinical diagnostic capabilities. Ancera R&D, Branford, CT 05/2020 – 01/2022
Senior Scientist-Molecular Biology, Research lead
• Led research in the development of molecular diagnostics for enteric bacterial detection.
• Developed FISH assays and optimized novel pathogen capture techniques using magnetic nanoparticles.
Nidhi Vishnoi, Ph.D. ***********@*****.*** • 732-***-**** linkedin.com/in/NidhiVishnoi
Yale School of Medicine Cell Biology, New Haven, CT 11/2012 – 04/2020 Postdoc. /Associate Research Scientist
• Discovered novel Nup188 roles related to congenital heart disease, and unveiled transcription dynamics of a cell cycle promoter leading to multiple high-impact publications.
• Conducted examinations of patent applications as Tech-Transfer Intern at the Yale Ventures. Kansas University Medical Center Kansas City, KS 01/2010 – 10/2012 Postdoctoral Fellow
• Demonstrated distinctive functions of yeast HIR complex, a DiGeorge Syndrome gene, in chromatin assembly and transcriptional regulation.
• Published three peer-reviewed articles and presented findings at Keystone conferences. Adjunct Teacher, Pillai’s College of Arts, Commerce & Science, 09/2009 – 12/2009
• Taught subject-specific material & learning strategies to Master’s student in Biotechnology.
• Assessed student progress by administering tests and evaluating results University of Mumbai India 12/2003 – 09/2009
PhD researcher
• Investigated Cyclin D1 overexpression mechanisms in hepatocarcinogenesis.
• Published multiple articles and was awarded several fellowships for research excellence. References
Dr. Philippe Prochasson
Vice President, Biosciences and Analytics & Head of SynBio Email: ********.**********@*****.*** Phone: 913-***-**** Dr. Anastasia Sevostiyanova
Principal Scientist, Ancera
Email: ***********@*****.*** Phone: 614-***-****
Publications
1. Vishnoi, N., et al. (2020). "Differential turnover of Nup188 controls its levels at centrosomes and role in centriole duplication." The Journal of Cell Biology, 219(3). 2. Rampello, J., Laudermilch, E., Vishnoi, N., et al. (2020). "Torsin ATPase deficiency leads to defects in nuclear pore biogenesis and sequestration of MLF2." The Journal of Cell Biology, 219(6). 3. Vishnoi, N., & Yao, J. (2017). "Single-cell, single-mRNA analysis of CCNB1 promoter regulation." Scientific Reports, 7, 2065.
4. Vishnoi, N., & Yao, J. (2014). "Gene positioning and genome function." Frontiers in Biology, 9, 255–268. 5. Amin, A. D., Vishnoi, N., et al. (2013). "A global requirement for the HIR complex in the assembly of chromatin." Biochimica et Biophysica Acta-GRM 1819, 264-276.
6. Amin, A. D., Dimova, D. K., Ferreira, M. E., Vishnoi, N., et al. (2012). "The mitotic Clb cyclins are required to alleviate HIR-mediated repression of the yeast histone genes at the G1/S transition." Biochimica et Biophysica Acta-GRM 1819(1), 16-27.
7. Vishnoi, N., et al. (2011). "Separation-of-function mutation in HPC2, a member of the HIR complex in S. cerevisiae, results in derepression of the histone genes but does not confer cryptic TATA phenotypes." Biochimica et Biophysica Acta-GRM, 1809, 557.